Jana et al., 2014 - Google Patents
Drug delivery in aortic valve tissue engineeringJana et al., 2014
View PDF- Document ID
- 1972356031258632237
- Author
- Jana S
- Simari R
- Spoon D
- Lerman A
- Publication year
- Publication venue
- Journal of Controlled Release
External Links
Snippet
Over the last 50 years medicine and technology have progressed to the point where it has become commonplace to safely replace damaged or diseased heart valves with mechanical and biological prostheses. Despite the advancements in technology current valve …
- 239000003814 drug 0 title abstract description 193
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with soft flexible valve members, e.g. tissue valves shaped like natural valves
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jana et al. | Drug delivery in aortic valve tissue engineering | |
Jana et al. | Bioprinting a cardiac valve | |
Hasan et al. | Micro and nanotechnologies in heart valve tissue engineering | |
Feric et al. | Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues | |
Gajendiran et al. | Conductive biomaterials for tissue engineering applications | |
EP4279036A3 (en) | Prosthetic heart valve delivery apparatus | |
Kim et al. | Dual-controlled release system of drugs for bone regeneration | |
Arsiwala et al. | Recent advances in micro/nanoscale biomedical implants | |
MX361339B (en) | Prosthetic heart valve delivery apparatus. | |
EP4410245A3 (en) | Transcatheter prosthetic heart valve and delivery system | |
IL277025B2 (en) | Methods for improving the differentiation of stem cells into beta cells | |
Laforenza et al. | Mammalian aquaglyceroporin function in metabolism | |
BR112017019934A2 (en) | heart valve therapy systems and methods | |
CR20190308A (en) | Systems and mechanisms for deploying a docking device for a replacement heart valve | |
Marsden et al. | Studies of retroviral infection in humanized mice | |
EP4269566A3 (en) | Genetic markers for engraftment of human cardiac ventricular progenitor cells | |
EP4389085A3 (en) | Steerable delivery system for replacement mitral valve and methods of use | |
MX2023003296A (en) | Generating atrial and ventricular cardiomyocyte lineages from human pluripotent stem cells. | |
EP4353203A3 (en) | Heart valve prosthesis delivery system | |
ATE530143T1 (en) | DEVICE FOR IMPLANTING COLLAPSIBLE/EXPANDABLE HEART VALVE PROSTHESIS | |
WO2012103173A3 (en) | Devices and methods for surgical and percutaneous repair of heart valve lesions | |
Li et al. | Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling | |
MX388573B (en) | Heart valve bioprosthesis and manufacturing method thereof | |
SG11201804755VA (en) | Method for manufacturing tissue/organ by using blood cells | |
CO2018000859A2 (en) | Humanized heart muscle |